Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Access brought to you by:

provisional account

See all formats and pricing


Select Volume and Issue


Exhaled breath analysis for early cancer detection: principle and progress in direct mass spectrometry techniques

1Department of Chemistry, Université de Montréal, Montréal, QC, Canada

Corresponding author: Koffi Badjagbo, Department of Chemistry, Université de Montréal, CP 6128 Centre-ville, Montréal, H3C 3J7, QC, Canada Phone: +1 514 343-6111 ext. 3921

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 50, Issue 11, Pages 1893–1902, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/cclm-2012-0208, May 2012

Publication History

Published Online:


Volatile biomarker analysis in exhaled breath is becoming one of the desirable strategies for cancer detection because it may offer a relatively inexpensive, rapid, and non-invasive screening method for early diagnosis. Breath analysis has attracted a considerable amount of scientific and clinical interest over the past decade. However, breath is not yet used for routine medical diagnostic purposes. Challenges faced in the development of breath analysis for cancer diagnosis include developing techniques that can measure biomarkers in exhaled breath at ultratrace levels, providing definitive evidence for their presence and for the relationship between the proposed biomarker and the underlying condition. Various analytical methods are used for the detection of breath biomarkers. Gas chromatography-based methods which involve sample collection, analyte preconcentration, desorption, and separation steps are the most popular. However, direct-sampling mass spectrometry techniques have been proven more reliable for air analysis without prior sample pretreatment or chromatographic separation. This review focuses on the most commonly used direct mass spectrometry methods for the direct online analysis of endogenous cancer biomarkers in exhaled breath, with particular attention to principle of detection, method performance, advantages, shortcomings, recent advances, and applications within health-related studies for cancer biomarkers research. The principle behind the science of breath analysis for cancer diagnosis is also discussed.

Keywords: cancer; direct-sampling mass spectrometry; exhaled breath; proton transfer reaction mass spectrometry; selected ion flow tube mass spectrometry; volatile biomarker

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Nuria Queralto, Anders N Berliner, Brett Goldsmith, Raymond Martino, Paul Rhodes, and Sung H Lim
Journal of Breath Research, 2014, Volume 8, Number 2, Page 027112
Stefan Hanf, Robert Keiner, Di Yan, Jürgen Popp, and Torsten Frosch
Analytical Chemistry, 2014, Volume 86, Number 11, Page 5278
Hiroyuki Kataoka, Keita Saito, Hisato Kato, and Kazufumi Masuda
Bioanalysis, 2013, Volume 5, Number 11, Page 1443

Comments (0)

Please log in or register to comment.